|
|||||
|
|
Bcl-2 family of proteins as drug targets for cancer chemotherapy: the long way of BH3 mimetics from bench to bedside |
|
| Affiliation: | 2. Department of Internal Medicine, University of South Dakota, Vermillion, SD;3. Genentech, South San Francisco, CA;1. Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA |
| Abstract: | |
| Keywords: | Navitoclax (PubChem CID: 24978538) ABT-737 (PubChem CID: 11228183) ABT-199 (PubChem CID: 49846579) Gossypol (PubChem CID: 3503) Obatoclax (PubChem CID: 16681698) |
| 本文献已被 ScienceDirect 等数据库收录！ | |